Cervical cancer patients with stage IVB, persistent, or recurrent disease after complete primary treatment are usually treated with systemic chemotherapy. | Neutrophil-lymphocyte ratio as a predictor of oncologic outcomes in stage IVB persistent or recurrent cervical cancer patients treated by chemotherapy